Darashana Punglia
University of Michigan
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Darashana Punglia.
Inflammatory Bowel Diseases | 2012
Jeremy Adler; Darashana Punglia; Jonathan R. Dillman; Alexandros D. Polydorides; Maneesh Dave; Mahmoud M. Al-Hawary; Joel F. Platt; Barbara J. McKenna; Ellen M. Zimmermann
Background: It has become commonplace to categorize small intestinal Crohns disease (CD) as “active” vs. “inactive” or “inflammatory” vs. “fibrotic” based on computed tomography enterography (CTE) findings. Data on histologic correlates of CTE findings are lacking. We aimed to compare CTE findings with histology from surgically resected specimens. We tested the hypothesis that CTE findings can distinguish tissue inflammation from fibrosis. Methods: Patients who underwent CTE within 3 months before intestinal resection for CD were retrospectively studied. Radiologists blinded to history and histology scored findings on CTE. Pathologists blinded to history and imaging scored resected histology. We compared histology with CTE findings and radiologists assessment of whether the stricture was likely “active” or “inactive.” Results: In all, 22 patients met inclusion criteria. Inflammatory CTE findings correlated with histologic inflammation (rho = 0.52). Strictures believed to be “active” on CTE were more inflamed at histology (P = 0.0002). Strictures lacking inflammatory findings on CTE or considered “inactive” were not associated with greater histologic fibrosis or significant histologic inflammation. Upstream dilation was associated with greater tissue fibrosis in univariate (P = 0.014) but not in multivariate analysis (P = 0.53). Overall, histologic fibrosis correlated best with histologic inflammation (rho = 0.52). Strictures on CTE with the most active disease activity also had the most fibrosis on histology. Conclusions: CTE findings of mesenteric hypervascularity, mucosal hyperenhancement, and mesenteric fat stranding predict tissue inflammation. However, small bowel stricture without CTE findings of inflammation does not predict the presence of tissue fibrosis. Therefore, caution should be used when using CTE criteria to predict the presence of scar tissue. (Inflamm Bowel Dis 2011;)
Inflammatory Bowel Diseases | 2017
Naueen A. Chaudhry; Michael Riverso; Joseph R. Grajo; Patricia P. Moser; Fei Zou; Maher Homsi; Darashana Punglia; Ellen M. Zimmermann
Background: Patients with Crohns disease (CD) typically undergo multiple cross-sectional imaging exams including computed tomography and magnetic resonance enterography during the course of their disease. The aim was to identify imaging findings that predict future disease-related poor outcomes. Methods: This was a retrospective, case control study at a single tertiary center. Cases were CD patients diagnosed with complications (bowel obstruction, perforation, internal fistula, or abscess); controls were CD patients without complications. Two radiologists blinded to clinical outcomes, independently scored cross-sectional imaging examinations obtained before the complication. Results: One hundred eight patients (67 F; 41 M) with CD (51 cases; 57 controls) were included. For the cases, 21 had internal fistulae, 15 had bowel obstructions, 13 had abdominal abscesses, and 2 developed bowel perforations. Patients with complications were more likely to have a fixed small bowel stricture on cross-sectional imaging (P = 0.01). A patient with a stricture and upstream dilatation was 3.4 times more likely to develop a complication in the next 2 years. When present in the setting of hypervascularity and/or evidence of active inflammation, the risk increased further to 15-fold. Cases were more likely to be active smokers (29% versus 12%, P = 0.033). Cases had more evidence of inflammation based on higher Harvey Bradshaw Index values and inflammatory biomarkers and lower hemoglobin values. Conclusions: Information from radiologic studies, especially the presence of fixed strictures, can predict future CD complications. These findings, along with smoking and ongoing inflammation, should alert the clinician to the possibility of future complications.
Gastroenterology | 2011
Elan H. Green; Mahmoud M. Al-Hawary; Darashana Punglia; Ellen M. Zimmermann; Jeremy Adler
Gastroenterology | 2013
Karla Helvie; Muhammad Dhanani; Mahmoud M. Al-Hawary; Jordi Rimola; Darashana Punglia; Jeremy Adler; Ellen M. Zimmermann
Gastroenterology | 2012
Joseph Duratinsky; Karla Helvie; Mahmoud M. Al-Hawary; Jeremy Adler; Darashana Punglia; Ellen M. Zimmermann
Gastroenterology | 2011
Tannaz Guivatchian; Karla Helvie; Caitlyn M. Plonka; Jeremy Adler; Darashana Punglia; Mahmoud M. Al-Hawary; Ellen M. Zimmermann
Gastroenterology | 2010
Tannaz Guivatchian; Andrace DeYampert; Darashana Punglia; Jeremy Adler; Mahmoud M. Al-Hawary; Ellen M. Zimmermann
Gastroenterology | 2009
Tina Vazirani; Jeremy Adler; Darashana Punglia; Andrace DeYampert; Peter D. Higgins; Phyllissa Schmiedlin-Ren; Peter Kuffa; Gabriel Nunez; Jose L. Fernandez-Luna; Ellen M. Zimmermann
Gastroenterology | 2009
Darashana Punglia; Jeremy Adler; Jonathan R. Dillman; Maneesh Dave; Mahmoud M. Al-Hawary; Paul L. Sonda; Joel F. Platt; Ellen M. Zimmermann
Gastroenterology | 2008
Darashana Punglia; Jeremy Adler; Maneesh Dave; Paul L. Sonda; Joel F. Platt; Ellen M. Zimmermann